• 靶点：
• Cripto-3

• 基因名称：
• TDGF1P3

• 蛋白名称：
• Putative teratocarcinoma-derived growth factor 3

• Human Swiss Prot No：
• P51864

• 免疫原：
• The antiserum was produced against synthesized peptide derived from the Internal region of human TDGF1P3. AA range:1-50

• 特异性：
• Cripto-3 Polyclonal Antibody detects endogenous levels of Cripto-3 protein.

• 组成：
• Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

• 来源：
• Polyclonal, Rabbit,IgG

• 稀释：
• WB 1:500 - 1:2000. ELISA: 1:10000. Not yet tested in other applications.

• 纯化工艺：
• The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

• 浓度：
• 1 mg/ml

• 储存：
• -15°C to -25°C/1 year(Do not lower than -25°C)

• 其他名称：
• TDGF1P3;CRIPTO3;TDGF2;TDGF3;Putative teratocarcinoma-derived growth factor 3;Cripto-3 growth factor;Epidermal growth factor-like cripto protein CR3;Teratocarcinoma-derived growth factor 1 pseudogene 3

• 实测条带：
• 21kD

• 背景：
• The TDGF3 locus has characteristics of a retrotransposon, including lack of introns and a poly(A) sequence. [provided by RefSeq, Jul 2008],

• 功能：
• function:Could play a role in the determination of the epiblastic cells that subsequently give rise to the mesoderm.,similarity:Contains 1 EGF-like domain.,tissue specificity:Preferentially expressed in gastric and colorectal carcinomas than in their normal counterparts.,

• 细胞定位：
• Cell membrane .

• 组织表达：
• Expressed weakly in lung, colon and breast. Expressed also strongly in primary cancer tissues; lung and colon cancers.

• June 19-2018
• WESTERN IMMUNOBLOTTING PROTOCOL

• June 19-2018
• IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL

• June 19-2018
• IMMUNOFLUORESCENCE PROTOCOL

• September 08-2020
• FLOW-CYTOMEYRT-PROTOCOL

• May 20-2022
• Cell-Based ELISA│解您多样本WB检测之困扰

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN

• July 13-2018
• CELL-BASED-COLORIMETRIC-ELISA-PROTOCOL-FOR-TOTAL-PROTEIN

• July 13-2018
• Antibody-FAQs